HomeLXEO • NASDAQ
add
Lexeo Therapeutics Inc
Previous close
$3.27
Day range
$3.30 - $4.21
Year range
$1.45 - $19.50
Market cap
128.80M USD
Avg Volume
883.03K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 16.63M | 120.35% |
Net income | -32.66M | -50.61% |
Net profit margin | — | — |
Earnings per share | -0.99 | -28.57% |
EBITDA | -33.66M | -45.50% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 99.83M | -48.82% |
Total assets | 125.69M | -41.05% |
Total liabilities | 37.58M | 24.19% |
Total equity | 88.12M | — |
Shares outstanding | 33.19M | — |
Price to book | 1.23 | — |
Return on assets | -62.00% | — |
Return on capital | -75.36% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -32.66M | -50.61% |
Cash from operations | -21.72M | -46.07% |
Cash from investing | 15.60M | 8,182.90% |
Cash from financing | 11.00K | -99.99% |
Net change in cash | -6.10M | -108.30% |
Free cash flow | -9.79M | -25.77% |
About
Founded
2017
Website
Employees
75
